BIOMX INC Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PHGEW and buy or sell other stocks, ETFs, and their options commission-free!About PHGEW
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively.
CEOJonathan Eithan Solomon, MBA
CEOJonathan Eithan Solomon, MBA
Employees—
Employees—
HeadquartersDover, Delaware
HeadquartersDover, Delaware
Founded2015
Founded2015
Employees—
Employees—
PHGEW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume34.92K
Average volume34.92K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0189
52 Week high$0.0189
52 Week low$0.0002
52 Week low$0.0002